John Lee
About John Lee
Title and Current Position of John Lee
John Lee currently holds the title of Senior Vice President (SVP) of Cell Therapy Manufacturing. In this role, he has led and supported the full spectrum of therapy discovery and development for nearly a dozen CAR-T programs. His expertise has been integral to the approval of cilta-cel (Carvykti), a notable advancement in the field.
John Lee's Educational Background
John Lee has a broad educational background in science and business. He holds a Ph.D. from the Brody School of Medicine, an MBA from Penn State University, and a Bachelor of Science degree from Indiana University of Pennsylvania. This combination of scientific and business education has equipped him with a comprehensive understanding of both the technical and managerial aspects of cell therapy manufacturing.
John Lee's Expertise in CAR-T Therapy
John Lee is an accomplished CAR-T immunobiologist with over 20 years of expertise in cancer cell biology. With more than 15 years dedicated to clinical research and cell therapy, his contributions have been pivotal to the advancement of CAR-T therapies. His work spans the discovery, preclinical development, and clinical application of these therapies.
Professional Experience of John Lee
Throughout his career, John Lee has held significant positions at renowned institutions. He has worked at The Wistar Institute, Janssen Pharmaceuticals, and GlaxoSmithKline. Notably, he built the Cell Therapy Platform team at Janssen Pharmaceuticals and served as Vice President, Head of Oncology Cell Therapy at GlaxoSmithKline. His efforts contributed to the establishment of multiple preclinical assets and clinical-stage programs targeting cancer-testis antigen NY-ESO.